We are close...
Huge tailwinds driving this company and their products.
Great investor sentiment surrounding MedTech, particularly in home-based therapies and precision-based personal care.
Clear and transparent strategy / revenue model communicated to market, with gross product margin of 68%...
No fluff management, all killer and no filler.
Azure Capita behind the deal.
Italian distribution agreement already signed with an obligation to purchase a minimum of 8,700 units up to July 2019. This agreement is almost to the value of market-cap on listing.
Big juicy markets to penetrate - http://www.neurotechindustry.org/access-to-capital
"In 2013, the 800 companies involved in the global neurotech industry generated $160 billion in revenue"
Not much to fault at this stage, add the ridiculously tiny market cap into the mix and you have a potential star.
- Forums
- ASX - By Stock
- NTI
- Code available for discussion
Code available for discussion, page-38
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
8.3¢ |
Change
-0.001(1.19%) |
Mkt cap ! $84.44M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.3¢ | $353.1K | 4.041M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61058 | 8.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 39000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12060 | 0.083 |
2 | 164064 | 0.082 |
3 | 37166 | 0.081 |
6 | 356708 | 0.080 |
1 | 70000 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 39000 | 1 |
0.087 | 116279 | 1 |
0.088 | 86000 | 1 |
0.089 | 58588 | 1 |
0.090 | 212500 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |